Direxion Daily Financial Bull 3X Shares ETF
FAS
Ultra Financials Proshares
UYG
Spdr S&P Bank Etf
KBE
4
SPDR S&P Metals & Mining ETF
XME
5
SPDR S&P Retail ETF
XRT
US Stock MarketDetailed Quotes
Citius Oncology (CTOR)
- 1.130
- +0.060+5.61%
Trading Dec 17 12:15 ET
95.82MMarket Cap-3.82P/E (TTM)
1.140High1.060Low290.31KVolume1.060Open1.070Prev Close318.48KTurnover5.86%Turnover RatioLossP/E (Static)84.80MShares6.19052wk High2.96P/B5.59MFloat Cap0.55152wk Low--Dividend TTM4.95MShs Float49.000Historical High--Div Yield TTM7.48%Range %0.551Historical Low1.097Avg Price1Lot Size
CTOR Stock Chart
Real-Time
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
CTOR Orderflow
Unit: --
CTOR Orderflow Trend
IntradayDayWeekMonth
No Data
Citius Oncology (CTOR) News
Express News | Citius Oncology Announces Agreement With Investor For Purchase And Sale Of 1,284,404 Shares At $1.09/Share In Registered Direct Offering; Concurrently Enters Agreement For Purchase And Sale Of 15,229,358 Shares Of Common Stock And Warrants To Purchase...
Express News | Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced at-the-Market Under Nasdaq Rules
Press Release: Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
Citius Oncology Enters Exclusive Distribution Agreement With Er-Kim For Exclusive LYMPHIR Distribution Across Turkey And Key Gulf Cooperation Council Countries; Agreement Expands Citius Oncology's International Strategy To A Total Of 19 Markets...
Express News | Citius Oncology Inc - Er-Kim to Be Exclusive Distributor of Lymphir in Turkey and GCC
Healthcare Stocks Reverse Some Recent Gains -- Healthcare Roundup
Citius Oncology (CTOR) Stock Forum
$Citius Oncology (CTOR.US)$ missing info on potential revenue on the new drug. Cash burn, private placement, and potential reverse split are big concern here.
1
4
$Citius Oncology (CTOR.US)$ product commercial should run atleast 50-100%. why no movement here. what am missing
5
1
$Citius Oncology (CTOR.US)$ added 1.49
4
$Citius Oncology (CTOR.US)$ good news
2
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)
151441283猎人 : The proportion of floating shares is very small, and there will be no reverse stock split. You can see that the shareholders all built their positions in the third quarter. Following their lead won’t cause issues. This price is basically at the bottom, suitable for long-term holding. The lower it goes, the more you should increase your position. It’s normal to be temporarily stuck in a losing position.
night spark : Now I see this sudden roller coaster
75572791 151441283猎人 : agreed. i traded this stock 6 momths back or so, and rode it from .67¢ to $6+ and change. we should get there again. that was when there was news about their upcoming drug release, today, we are at the release!!
151441283猎人 75572791 : The second-largest shareholder significantly increased their position in the third quarter. This institution primarily invests in pharmaceutical stocks, and institutions generally conduct thorough research. Following their lead tends to result in a higher probability of success.